San Francisco, CA, United States of America

Kendall Hoff

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Centrillion Technology Holdings Corporation. Active years: 2021-2022.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents.

Title: Inventor Spotlight: Kendall Hoff

Introduction:

Kendall Hoff, a prolific inventor based in San Francisco, CA, has made significant contributions to the field of enzymatic synthesis of oligonucleotides. With a total of 2 patents to his name, Hoff's innovative work has been instrumental in advancing biotechnology.

Latest Patents:

1. Method and System for Enzymatic Synthesis of Oligonucleotides: Hoff's groundbreaking patent focuses on enzymatically synthesizing single-stranded oligonucleotides from an immobilized primer using a polymerase. This method allows for the synthesis of oligonucleotides in the presence of deoxyribonucleotide triphosphates or ribonucleotide triphosphates.

2. Disulfide-Linked Reversible Terminators: Another cutting-edge patent by Hoff involves sequencing polynucleotides using compounds with a unique sugar moiety and base structure. These compounds contain a cleavable chemical group capping the 3'-OH group and a base linked to a label through a disulfide bond cleavable by a chemical reagent.

Career Highlights:

Hoff is affiliated with Centrillion Technology Holdings Corporation, a prominent company in the biotechnology sector. His work at Centrillion has been pivotal in developing innovative technologies for genomic research and sequencing.

Collaborations:

Hoff's collaborative efforts with coworkers Wei Zhou and Michelle Halpain have led to the successful implementation of his patented technologies in real-world applications. Together, they have pushed the boundaries of biotechnology and molecular biology.

Conclusion:

Kendall Hoff's inventive spirit and dedication to advancing enzymatic synthesis and sequencing technologies have cemented his reputation as a trailblazer in the field of biotechnology. His patents stand as a testament to his expertise and commitment to driving innovation forward.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…